The CAMINISA brand, founded in 2014 (United States), from 61 sister brands and 17477 competing brands. CAMINISA is owned by Biogen Idec, listed on the stock exchange of New York CAMINISA belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
Biogen Idec
(CAMINISA)
over 5 years*
USD 177.58